Subscribe to Imaging
View Sample

FREE Email Newsletter

Crothall Healthcare Selects 3Mâ„¢ Clean-Traceâ„¢ for Infection Control Verification

December 28, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., Dec. 28, 2010 /- Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control. Crothall Environmental Services teams will use a...

Allscripts Sunrise Electronic Health Record Receives ONC-ATCB 2011/2012 Certification as 'Complete EHR'

December 28, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Dec. 28, 2010 /- Allscripts (Nasdaq: MDRX ) announced today that Sunrise Acute Care, Version 5.5 and Sunrise Emergency Care Version 5.5 are 2011/2012 CCHIT compliant and were certified as Complete EHRs on December 21, 2010 by the Certification Commission for Health Information...

Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai

December 28, 2010 1:31 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 28, 2010 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical") a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today reported that a...


K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission(2)

December 27, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Dec. 27, 2010 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) today announced the filing of its Form 10-K for its fiscal year ended March 31, 2010 with the Securities and Exchange Commission.  As a result, the Company has met the deadline for filing its delayed fiscal 2010...

Topical China Industries Research Reports Published at

December 27, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 27, 2010 /- Market Publishers Ltd informs that new in-demand ResearchInChina reports on China industries have been added to its catalogue. China Beer Industry Report, 2009-2010 . The report discusses development of China beer industry, provides detailed analysis of key beer...

Market Publishers Ltd and GenericsWeb Sign Partnership Agreement

December 27, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 27, 2010 /- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. is now authorized to distribute and sell GenericsWeb research reports . Mrs. Alla Martin, Head of Partner Relations...

Lloydspharmacy Reveals Couples Beleaguered by Monthly Cramps

December 24, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

COVENTRY, England, Dec. 24, 2010 /- New research from Lloydspharmacy reveals that whilst an overwhelming number of women suffer from menstrual cramps, male partners' sympathy levels at that time of the month appear to be lacking. Although 87% of men claim to be very or fairly...

Webcast Alert: Heska Corporation's Special Meeting of Stockholders Webcast

December 22, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., Dec. 22, 2010 /- Heska Corporation (Nasdaq: HSKA ) announces the following Webcast:What: Heska Corporation Invites You to Listen to Its Special Meeting of Stockholders on the WebWhen: Wednesday, December 29, @ 9:00 a.m. (MST)Where: (click on the Special...


Still River Systems targets 2012 for first proton beam radiation treatments

December 21, 2010 7:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Proton beam radiation therapy is recognized as a safer alternative to conventional X-ray radiation therapy, says Joe Jachinowski, CEO of Still River Systems Inc. But its slow adoption is all about price, he said. Still River Systems hopes to soon prove that it's taken a huge step toward...

New researcher needs in the lab mean new challenges for architects

December 21, 2010 7:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

In an effort to create more open laboratory spaces to provide easier access to other people and shared equipment, architects are taking a closer look at support space, areas such as cold rooms, tissue culturing rooms, and other specialized spaces where researchers spend a lot of time.

Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetac...

December 21, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill. and OSAKA, Japan, Dec. 21, 2010 /- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc. ("TPNA"), have completed settlements with all defendants in patent litigation brought...

MiMedx Announces Agreement to Acquire Surgical Biologics

December 21, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

MARIETTA, Ga., Dec. 21, 2010 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG ), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has signed a definitive agreement to acquire Surgical Biologics, a leader in the...

Advanced Laser Therapy Solutions for Women's Hair Loss

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Many Women suffering from hair loss are turning to Advanced Hair Studio s and discovering advanced laser therapy as a method along with other procedures to overcome thinning hair. This method of hair restoration has been shown to be affective in helping a woman's...


Silence Therapeutics Provides Year-end Update

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today...

Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors

December 20, 2010 12:33 pm | by Boston Scientific | News | Comments

NATICK, Mass., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Kristina M. Johnson, Ph.D., as a Director, effective January 1

The Center for Business Intelligence (CBI) Receives Top 100 Women-Led Businesses Award

December 20, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass., Dec. 20, 2010 /- The Center for Business Intelligence (CBI) has been recognized as a Top 100 Women-Led Business in Massachusetts in 2009. The honor was awarded recently to Kathleen Y. Coffey, CBI President, by the Boston Business Journal and The Commonwealth Institute at...

FDA CONSUMER HEALTH INFORMATION - Generic Drug Roundup: December 2010

December 20, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Dec. 20, 2010 /PRNewswire-USNewswire/ -- Each year, the Food and Drug Administration (FDA) approves many generic drugs that treat a wide variety of conditions and help consumers save money. To read about recent significant FDA approvals for generic medications, go to...

Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call

December 20, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Dec. 20, 2010 /- Varian Medical Systems (NYSE: VAR ) announced today that it will report results for first quarter of fiscal year 2011 following the close of regular trading on Wednesday, January 26, 2011.  The news release will be followed by a teleconference...

St Helens & Knowsley Teaching Hospitals NHS Trust wins healthcare IT category at the 2010 Health Business Awards

December 20, 2010 3:37 am | by RealWire | News | Comments

The third award received this year for landmark electronic medical records project December 20, 2010 - C Cube Solutions and Kodak (NYSE:EK) today announce that Merseyside-based St Helens & Knowsley Teaching Hospitals NHS Trust has won the healthcare IT category at the 2010 Health...

Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study i...

December 19, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Dec. 20, 2010 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, December 20, to discuss results of the Phase 3 COPERNICUS study with VEGF Trap-Eye in central retinal vein...

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

December 17, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  ...

Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research

December 17, 2010 2:31 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Dec. 17, 2010 /- More than half of older Americans who were prescribed antidepressants for the first time were already taking a medication that could adversely interact with the antidepressant , according to a new study from Thomson Reuters. For one-fourth of the seniors...

Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO and ILLKIRCH, France, Dec. 16, 2010 /- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a...

Watson and Richter Announce Exclusive License Agreement for Esmyaâ„¢

December 15, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A.,...

SABCS 2010 Interview with Amelie G. Ramirez, Dr.P.H.

December 15, 2010 1:33 pm | by AACR | News | Comments

Dr. Ramirez discusses the importance of genetic testing for breast cancer among Latinas, statewide and national communications programs, challenges facing the Hispanic community in reference to cancer, and how to address some of these concerns.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.